Puma Biotechnology (PBYI)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Fiscal Year End Date: 12/31
| 03-2022 | 12-2021 | 09-2021 | 06-2021 | 03-2021 | |
| Cash Flows From Operating Activities | |||||
| Net Income | -3,403 | -29,126 | -33,350 | 11,322 | 16,528 |
| Depreciation Amortization | 2,457 | 11,305 | 8,327 | 5,886 | 2,951 |
| Accounts receivable | 5,487 | -5,983 | 2,744 | -4,006 | -615 |
| Accounts payable and accrued liabilities | -3,762 | -902 | 7,971 | -910 | -1,422 |
| Other Working Capital | -29,098 | -1,309 | 15,581 | -24,720 | -9,678 |
| Other Operating Activity | 1,424 | 46,665 | 24,812 | 28,015 | 7,897 |
| Operating Cash Flow | $-26,895 | $20,650 | $26,085 | $15,587 | $15,661 |
| Cash Flows From Investing Activities | |||||
| Purchase Of Investment | N/A | -38,073 | -38,073 | -19,117 | -10,696 |
| Sale Of Investment | 8,982 | 27,192 | 22,571 | 8,085 | 5,395 |
| Investing Cash Flow | $8,982 | $-10,881 | $-15,502 | $-11,032 | $-5,301 |
| Cash Flows From Financing Activities | |||||
| Debt Issued | N/A | 98,500 | 98,500 | N/A | N/A |
| Debt Repayment | N/A | -100,000 | -100,000 | N/A | N/A |
| Common Stock Issued | 10,000 | N/A | N/A | N/A | N/A |
| Other Financing Activity | -155 | -30,431 | -30,429 | 0 | 0 |
| Financing Cash Flow | $9,845 | $-31,931 | $-31,929 | $N/A | $N/A |
| Beginning Cash Position | 75,292 | 97,454 | 97,454 | 97,454 | 97,454 |
| End Cash Position | 67,224 | 75,292 | 76,108 | 102,009 | 107,814 |
| Net Cash Flow | $-8,068 | $-22,162 | $-21,346 | $4,555 | $10,360 |
| Free Cash Flow | |||||
| Operating Cash Flow | -26,895 | 20,650 | 26,085 | 15,587 | 15,661 |
| Free Cash Flow | -26,895 | 20,650 | 26,085 | 15,587 | 15,661 |